A mention of Kalorama's personalized medicine market forecast in this Healthcare IT News article. The magazine is published by HIMSS, the top trade association for tech companies involved in the healthcare space.
Thus its not surprising that they make note of the digital connection to personalized medicine(PMx); the tech that will be needed to analyze data gathered to make the concept more of a reality. And they note GE's recent acquisition of NanoString, whose nCounter Analysis System, is a fully automated platform for digital gene expression and other applications requiring the detection and counting of single molecules.
They also note Dell's recent launching of a cloud computing technology to support pediatric cancer research programs, including what's billed as the world's first personalized medicine trial for pediatric cancer, conducted by the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) and supported by the Translational Genomics Research Institute.
